Key result
Review details CVD epidemiology, early detection, and cardioprotective therapies for breast cancer survivors.
This review emphasizes the need for multidisciplinary cardiovascular care, early detection, and cardioprotective strategies for the growing population of breast cancer survivors.
May inform cardio-oncology monitoring in survivors; leaves open prospective validation of strategies.
Breast cancer is the most common malignancy in women with more than 3 million breast cancer survivors in the United States alone. Survivors of breast cancer suffer from an increased burden of cardiovascular risk factors and disease. The focus of this review is to describe the epidemiology of cardiovascular disease in breast cancer survivors, including the cardiovascular concerns observed with common cancer therapies. Strategies to improve upon the early detection and treatment of cardiovascular disease, including clinical prediction algorithms, biomarkers, and imaging measures are also reviewed, and the use of cardioprotective therapies to mitigate risk are summarized. Finally, the need for evidence-based research to inform and improve upon the multidisciplinary care of this growing population is highlighted.
No takes yet. Share an insight, caveat, or question.
Bonnie Ky (2018) conducted a review in Breast cancer and cardiovascular disease. This review describes the epidemiology of cardiovascular disease in breast cancer survivors and summarizes strategies for early detection and cardioprotective therapies to mitigate risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: